Announcing the novel class of GABA-A receptor selective positive allosteric modulator antidepressants.
作者信息
Fasipe Olumuyiwa John, Agede Olalekan Ayodele, Enikuomehin Adenike Christiana
机构信息
Department of Clinical Pharmacology & Therapeutics, Faculty of Basic Clinical Sciences, University of Medical Sciences, Ondo City, Ondo State, Nigeria.
Department of Clinical Pharmacology & Therapeutics, Faculty of Basic Clinical Sciences, University of Ilorin, Ilorin, Kwara State, Nigeria.
出版信息
Future Sci OA. 2020 Nov 12;7(2):FSO654. doi: 10.2144/fsoa-2020-0108.
Abstract
摘要
相似文献
1
Announcing the novel class of GABA-A receptor selective positive allosteric modulator antidepressants.
Future Sci OA. 2020 Nov 12;7(2):FSO654. doi: 10.2144/fsoa-2020-0108.
2
Zuranolone - synthetic neurosteroid in treatment of mental disorders: narrative review.
Front Psychiatry. 2023 Dec 5;14:1298359. doi: 10.3389/fpsyt.2023.1298359. eCollection 2023.
3
Advances in pharmacotherapy for postpartum depression: a structured review of standard-of-care antidepressants and novel neuroactive steroid antidepressants.
Ther Adv Psychopharmacol. 2022 Jan 28;12:20451253211065859. doi: 10.1177/20451253211065859. eCollection 2022.
4
Development of neuroactive steroids for the treatment of postpartum depression.
J Neuroendocrinol. 2022 Feb;34(2):e13019. doi: 10.1111/jne.13019. Epub 2021 Aug 30.
5
Neuroactive steroids - new possibilities in the treatment of postpartum depression.
Ceska Slov Farm. 2022 Fall;71(4):142-150.
6
Exploring the clinical potentials of zuranolone in managing postpartum depression: A new therapeutic horizon.
Prog Neuropsychopharmacol Biol Psychiatry. 2024 Jun 8;132:110983. doi: 10.1016/j.pnpbp.2024.110983. Epub 2024 Feb 25.
7
Intravenous brexanolone for postpartum depression: what it is, how well does it work, and will it be used?
Ther Adv Psychopharmacol. 2020 Nov 9;10:2045125320968658. doi: 10.1177/2045125320968658. eCollection 2020.
8
Modification of behavioral effects of drugs in mice by neuroactive steroids.
Psychopharmacology (Berl). 2000 Mar;148(4):336-43. doi: 10.1007/s002130050060.
9
The Emerging Role of Neurosteroids: Novel Drugs Brexanalone, Sepranolone, Zuranolone, and Ganaxolone in Mood and Neurological Disorders.
Cureus. 2024 Jul 31;16(7):e65866. doi: 10.7759/cureus.65866. eCollection 2024 Jul.
引用本文的文献
1
Role of Biosynthesis and Catabolism of Neurotransmitters in Drug Discovery for Anxiety and Depression.
Curr Pharm Des. 2024;30(33):2587-2596. doi: 10.2174/0113816128309913240704095334.
2
New Pharmacological Therapies in the Treatment of Epilepsy in the Pediatric Population.
J Clin Med. 2024 Jun 18;13(12):3567. doi: 10.3390/jcm13123567.
3
Phenols and GABA receptors: from structure and molecular mechanisms action to neuropsychiatric sequelae.
Front Pharmacol. 2024 Jan 18;15:1272534. doi: 10.3389/fphar.2024.1272534. eCollection 2024.
4
Depression pathophysiology, risk prediction of recurrence and comorbid psychiatric disorders using genome-wide analyses.
Nat Med. 2023 Jul;29(7):1832-1844. doi: 10.1038/s41591-023-02352-1. Epub 2023 Jul 18.
5
The pharmacological bases for repurposing statins in depression: a review of mechanistic studies.
Transl Psychiatry. 2023 Jul 12;13(1):253. doi: 10.1038/s41398-023-02533-z.
6
Role of allopregnanolone-mediated γ-aminobutyric acid A receptor sensitivity in the pathogenesis of premenstrual dysphoric disorder: Toward precise targets for translational medicine and drug development.
Front Psychiatry. 2023 Mar 2;14:1140796. doi: 10.3389/fpsyt.2023.1140796. eCollection 2023.
7
Welcome to volume 8 of .
Future Sci OA. 2021 Dec 1;8(1):FSO767. doi: 10.2144/fsoa-2021-0124. eCollection 2022 Jan.
本文引用的文献
1
Neurosteroids as novel antidepressants and anxiolytics: GABA-A receptors and beyond.
Neurobiol Stress. 2019 Sep 27;11:100196. doi: 10.1016/j.ynstr.2019.100196. eCollection 2019 Nov.
2
The emergence of new antidepressants for clinical use: Agomelatine paradox versus other novel agents.
IBRO Rep. 2019 Jan 9;6:95-110. doi: 10.1016/j.ibror.2019.01.001. eCollection 2019 Jun.
3
Brexanolone: First Global Approval.
Drugs. 2019 May;79(7):779-783. doi: 10.1007/s40265-019-01121-0.
4
Pharmacotherapy of Postpartum Depression: Current Approaches and Novel Drug Development.
CNS Drugs. 2019 Mar;33(3):265-282. doi: 10.1007/s40263-019-00605-7.
5
A new generation of antidepressants: an update on the pharmaceutical pipeline for novel and rapid-acting therapeutics in mood disorders based on glutamate/GABA neurotransmitter systems.
Drug Discov Today. 2019 Feb;24(2):606-615. doi: 10.1016/j.drudis.2018.11.007. Epub 2018 Nov 14.
6
Neuroactive Steroids. 2. 3α-Hydroxy-3β-methyl-21-(4-cyano-1H-pyrazol-1'-yl)-19-nor-5β-pregnan-20-one (SAGE-217): A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (γ-Aminobutyric Acid) Receptor.
J Med Chem. 2017 Sep 28;60(18):7810-7819. doi: 10.1021/acs.jmedchem.7b00846. Epub 2017 Aug 17.
7
Neurosteroids: endogenous role in the human brain and therapeutic potentials.
Prog Brain Res. 2010;186:113-37. doi: 10.1016/B978-0-444-53630-3.00008-7.
8
The GABAergic deficit hypothesis of major depressive disorder.
Mol Psychiatry. 2011 Apr;16(4):383-406. doi: 10.1038/mp.2010.120. Epub 2010 Nov 16.
9
Clinical evaluation of ganaxolone in pediatric and adolescent patients with refractory epilepsy.
Epilepsia. 2007 Oct;48(10):1870-4. doi: 10.1111/j.1528-1167.2007.01182.x. Epub 2007 Jul 18.
10
Allopregnanolone analogs that positively modulate GABA receptors protect against partial seizures induced by 6-Hz electrical stimulation in mice.
Epilepsia. 2004 Jul;45(7):864-7. doi: 10.1111/j.0013-9580.2004.04504.x.
Zotero 插件